Prothymosin-? interacts with mutant huntingtin and suppresses its cytotoxicity in cell culture.

ABSTRACT: Huntington disease (HD), a fatal neurodegenerative disorder, is caused by a lengthening of the polyglutamine tract in the huntingtin (Htt) protein. Despite considerable effort, thus far there is no cure or treatment available for the disorder. Using the approach of tandem affinity purification we recently discovered that prothymosin-? (ProT?), a small highly acidic protein, interacts with mutant Htt (mHtt). This was confirmed by co-immunoprecipitation and a glutathione S-transferase (GST) pull-down assay. Overexpression of ProT? remarkably reduced mHtt-induced cytotoxicity in both non-neuronal and neuronal cell models expressing N-terminal mHtt fragments, whereas knockdown of ProT? expression in the cells enhanced mHtt-caused cell death. Deletion of the central acidic domain of ProT? abolished not only its interaction with mHtt but also its protective effect on mHtt-caused cytotoxicity. Additionally, overexpression of ProT? inhibited caspase-3 activation but enhanced aggregation of mHtt. Furthermore, when added to cultured cells expressing mHtt, the purified recombinant ProT? protein not only entered the cells but it also significantly suppressed the mHtt-caused cytotoxicity. Taken together, these data suggest that ProT? might be a novel therapeutic target for treating HD and other polyglutamine expansion disorders.

SUBMITTER: Dong G 

PROVIDER: S-EPMC3256907 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature